---
title: "ECO 2026: REDEFINE-1 demonstrates CagriSema’s improvement in body composition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286276857.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-13T13:52:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286276857.md)
  - [en](https://longbridge.com/en/news/286276857.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286276857.md)
---

# ECO 2026: REDEFINE-1 demonstrates CagriSema’s improvement in body composition

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [159898.CN](https://longbridge.com/en/quote/159898.CN.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)

## Related News & Research

- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [IceCure ProSense kidney cancer trial shows 89.4% recurrence-free rate at 4 years](https://longbridge.com/en/news/286912762.md)